HFA Premium Access

Evolution of low risk natriuretic peptide to higher risk - Do we have a phenotype?

Congress Presentation

About the speaker

Doctor Nial Blake

Cardiovascular Research Institute, Mater Private, Dublin (Ireland)
0 follower

10 more presentations in this session

Role of neprilysin in myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Speaker: Doctor N. Pavo (Vienna, AT)


The value of tubular maximum phosphate reabsorption capacity, a functional proximal tubular parameter in heart failure

Speaker: Ms L. Emmens (Groningen, NL)


The risk of bias of current novel circulating biomarker studies for the detection of HFpEF and left ventricular diastolic dysfunction

Speaker: Mr M. Henkens (Maastricht, NL)


The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients

Speaker: Doctor R. Nielsen (Aarhus, DK)


Improvement of existing strategies to prevent heart failure after myocardial infarction: a potential role for thrombopoietin

Speaker: Associate Professor L. Malinova (Saratov, RU)


Access the full session

Rapid Fire 2 - Biomarker: present and future

Speakers: Doctor N. Blake, Doctor N. Pavo, Ms L. Emmens, Mr M. Henkens, Doctor R. Nielsen...

About the event


Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Related content

ESC Premium Access

The Day in Focus - Monday 30 August - Panel.

30 August 2021

Open Access

The value of NT-proBNP in cardiovascular risk stratification and optimization of cardioprotective treatment among patients with type 2 diabetes.

30 August 2021

ESC 365 is supported by

logo Novo Nordisk